SEATTLE, Nov. 18, 2021 /PRNewswire/ -- Five patients with mild to moderate dementia received a proprietaryintranasal dual gene therapy composed of hTERT and Klotho. The treatment demonstrated an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback